Stay updated on Filgotinib in RA: Safety & Efficacy (FINCH 4) Clinical Trial
Sign up to get notified when there's something new on the Filgotinib in RA: Safety & Efficacy (FINCH 4) Clinical Trial page.

Latest updates to the Filgotinib in RA: Safety & Efficacy (FINCH 4) Clinical Trial page
- CheckyesterdayChange DetectedThe footer revision changed from v3.7.2 to v3.8.0 while the page continued to display a 403 error.SummaryDifference0.2%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedA sitewide NIH transition notice appears above the ClinicalTrials.gov navigation, and the site revision advances from v3.7.1 to v3.7.2 while the study page still displays a 403 error.SummaryDifference1%

- Check29 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check36 days agoChange DetectedRemoved the 403 Forbidden content and the Home link from the page, effectively eliminating the access-denied snippet and its navigation element from the visible content.SummaryDifference0.5%

- Check43 days agoChange DetectedThe study page now displays a 403 Forbidden error for the NCT03025308 record, replacing the expected content with an access-restricted error screen.SummaryDifference16%

- Check50 days agoChange DetectedThe page now shows Revision: v3.7.0, indicating an updated document version. It replaces the prior Revision: v3.6.6.SummaryDifference0.0%

Stay in the know with updates to Filgotinib in RA: Safety & Efficacy (FINCH 4) Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Filgotinib in RA: Safety & Efficacy (FINCH 4) Clinical Trial page.